ABVX short interest
Abivax S.A. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 7,776,429 |
|---|---|
| Change vs prior report | 917,918 (+13.4%) |
| Change over six months | +138.0% |
| Days to cover | 5.05 (sector: 3.78) |
| Average daily volume | 1,540,598 |
| Rank in Healthcare | #412 of 922 by days to cover |
ABVX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 7,776,429 | +13.4% | 5.05 | 1,540,598 |
| 2026-09-15 | 6,858,511 | -1.5% | 6.16 | 1,114,113 |
| 2026-08-31 | 6,962,029 | +16.0% | 7.97 | 873,629 |
| 2026-08-14 | 6,001,787 | +15.5% | 7.84 | 765,619 |
| 2026-07-31 | 5,194,797 | +29.3% | 5.05 | 1,029,141 |
| 2026-07-15 | 4,018,322 | -7.1% | 2.36 | 1,705,540 |
| 2026-06-30 | 4,325,904 | -11.5% | 1.45 | 2,991,256 |
| 2026-06-15 | 4,887,145 | +60.0% | 1.19 | 4,102,529 |
| 2026-05-29 | 3,053,530 | +23.1% | 2.52 | 1,212,239 |
| 2026-05-15 | 2,480,049 | -2.6% | 2.98 | 833,182 |
| 2026-04-30 | 2,545,174 | -0.6% | 3.15 | 809,010 |
| 2026-04-15 | 2,561,260 | -21.6% | 3.04 | 841,542 |
| 2026-03-31 | 3,266,931 | -1.5% | 2.71 | 1,206,481 |
| 2026-03-13 | 3,315,979 | +1.5% | 3.68 | 901,879 |
| 2026-02-27 | 3,268,303 | +3.0% | 4.17 | 782,842 |
| 2026-02-13 | 3,172,758 | -13.2% | 4.68 | 677,411 |
| 2026-01-30 | 3,656,705 | +18.8% | 3.93 | 931,603 |
| 2026-01-15 | 3,078,950 | +5.9% | 1.30 | 2,361,227 |
| 2025-12-31 | 2,908,643 | +25.0% | 1.67 | 1,741,255 |
| 2025-12-15 | 2,327,324 | +1.4% | 1.21 | 1,922,250 |
| 2025-11-28 | 2,296,266 | +28.1% | 1.55 | 1,477,009 |
| 2025-11-14 | 1,792,054 | +4.5% | 1.62 | 1,103,004 |
| 2025-10-31 | 1,715,643 | +25.8% | 1.67 | 1,024,928 |
| 2025-10-15 | 1,363,331 | +9.8% | 1.21 | 1,126,043 |
| 2025-09-30 | 1,241,792 | -31.8% | 1.40 | 889,937 |
import finzdata as yf
yf.Ticker("ABVX").short_interest # every report since 2017
yf.Client().short_interest(["ABVX"], start="2018-01-01")Healthcare short interest · ABVX price history · Who owns ABVX · All short interest